Key facts
- Exxat’s last known valuation is $217.0M (Jan 2026).
- It has raised $45.0M; the latest was PE Growth/Expansion ($45.0M) in Jan 2026.
- Notable investors include Accel-KKR.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Exxat
- ·The full record, as it builds
Funding rounds
No funding rounds for Exxat are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Exxat
Developer of an education management platform designed to improve clinical educational outcomes. The company offers solutions for curriculum management, competency tracking, accreditation support, placement coordination, site collaboration, compliance tracking, workflow streamlining, and contract sharing, thereby helping institutions administer and scale allied health and clinical education programs in a unified manner.
- Sector
- Information Technology
- HQ
- Warren, NJ, United States
- Founded
- 2011
- Employees
- 434
- Website
- exxat.com/
- Ownership
- Privately Held (backing)
Exxat doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exxat shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exxat in its N-PORT filings yet. We sweep new filings monthly.